These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
491 related articles for article (PubMed ID: 27129161)
1. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium. Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161 [TBL] [Abstract][Full Text] [Related]
2. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma]. Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967 [No Abstract] [Full Text] [Related]
4. Lineage tracing suggests that ovarian endosalpingiosis does not result from escape of oviductal epithelium. Wang Y; Sessine MS; Zhai Y; Tipton C; McCool K; Kuick R; Connolly DC; Fearon ER; Cho KR J Pathol; 2019 Oct; 249(2):206-214. PubMed ID: 31131879 [TBL] [Abstract][Full Text] [Related]
5. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma. de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239 [TBL] [Abstract][Full Text] [Related]
6. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development. Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535 [TBL] [Abstract][Full Text] [Related]
7. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma]. Xiang L; Li J; Wang LJ; Zheng WX; Kong BH Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344 [TBL] [Abstract][Full Text] [Related]
8. Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface. Karthikeyan S; Lantvit DD; Chae DH; Burdette JE Oncotarget; 2016 Oct; 7(43):69871-69882. PubMed ID: 27563818 [TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton. Hardy LR; Pergande MR; Esparza K; Heath KN; Önyüksel H; Cologna SM; Burdette JE Oncogene; 2019 Aug; 38(32):6003-6016. PubMed ID: 31296958 [TBL] [Abstract][Full Text] [Related]
10. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma. Zhang S; Dolgalev I; Zhang T; Ran H; Levine DA; Neel BG Nat Commun; 2019 Nov; 10(1):5367. PubMed ID: 31772167 [TBL] [Abstract][Full Text] [Related]
11. PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome. Salvi A; Hardy LR; Heath KN; Watry S; Pergande MR; Cologna SM; Burdette JE Neoplasia; 2023 Feb; 36():100866. PubMed ID: 36586182 [TBL] [Abstract][Full Text] [Related]
12. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients. Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906 [TBL] [Abstract][Full Text] [Related]
13. PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma. Ghannam-Shahbari D; Jacob E; Kakun RR; Wasserman T; Korsensky L; Sternfeld O; Kagan J; Bublik DR; Aviel-Ronen S; Levanon K; Sabo E; Larisch S; Oren M; Hershkovitz D; Perets R Oncogene; 2018 Apr; 37(17):2213-2224. PubMed ID: 29379162 [TBL] [Abstract][Full Text] [Related]
14. Mutant p53 expression in fallopian tube epithelium drives cell migration. Quartuccio SM; Karthikeyan S; Eddie SL; Lantvit DD; Ó hAinmhire E; Modi DA; Wei JJ; Burdette JE Int J Cancer; 2015 Oct; 137(7):1528-38. PubMed ID: 25810107 [TBL] [Abstract][Full Text] [Related]
15. Tubal origin of 'ovarian' low-grade serous carcinoma. Li J; Abushahin N; Pang S; Xiang L; Chambers SK; Fadare O; Kong B; Zheng W Mod Pathol; 2011 Nov; 24(11):1488-99. PubMed ID: 21701538 [TBL] [Abstract][Full Text] [Related]
16. Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis. Banet N; Kurman RJ Int J Gynecol Pathol; 2015 Jan; 34(1):3-8. PubMed ID: 25473746 [TBL] [Abstract][Full Text] [Related]
17. Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators. Moyle-Heyrman G; Schipma MJ; Dean M; Davis DA; Burdette JE J Ovarian Res; 2016 Feb; 9():5. PubMed ID: 26879975 [TBL] [Abstract][Full Text] [Related]
18. The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae. Auersperg N Int J Gynecol Pathol; 2013 Sep; 32(5):444-53. PubMed ID: 23896717 [TBL] [Abstract][Full Text] [Related]